ClariVest Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.83M Hold
285,627
0.19% 152
2024
Q2
$1.83M Buy
285,627
+3,302
+1% +$21.2K 0.19% 152
2024
Q1
$2.13M Buy
282,325
+212,425
+304% +$1.94M 0.22% 125
2023
Q4
$647K Buy
69,900
+1,659
+2% +$13.6K 0.04% 334
2023
Q3
$691K Hold
68,241
0.04% 308
2023
Q2
$853K Buy
+68,241
New +$813K 0.04% 270

Other funds holding HCAT

ClariVest Asset Management's HCAT Position: Q3 2024 in Review

ClariVest Asset Management held its Health Catalyst (HCAT) position steady in Q3 2024 at 285,627 shares worth $1.83M. The position accounts for 0.19% of the portfolio, ranked #152.

ClariVest Asset Management first reported a position in HCAT in Q2 2023 and has held it in 6 quarters since. The position peaked at $2.13M in Q1 2024. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • ClariVest Asset Management held 285,627 shares of Health Catalyst worth $1.83M as of Q3 2024.
  • ClariVest Asset Management left its Health Catalyst share count unchanged in Q3 2024.
  • Health Catalyst made up 0.19% of ClariVest Asset Management's portfolio in Q3 2024, its #152 holding.
  • ClariVest Asset Management first reported a position in Health Catalyst in Q2 2023 and has held it in 6 quarters since.
  • ClariVest Asset Management's Health Catalyst position peaked at $2.13M in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.